Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Biologic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Biologic Drugsmarket, defines the market attractiveness level of Biologic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Biologic Drugs industry, describes the types of Biologic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biologic Drugs market and the development prospects and opportunities of Biologic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biologic Drugs market in Chapter 13.
By Player:
Merck & Co
Abbott Laboratories
Roche
Johnson & Johnson
Novartis
Pfizer
Eli Lilly
Sanofi
Amgen
By Type:
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By End-User:
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Biologic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Biologic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Biologic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Biologic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Biologic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Biologic Drugs Consumption (2017-2022)
-
7.2 United States Biologic Drugs Consumption (2017-2022)
-
7.3 Europe Biologic Drugs Consumption (2017-2022)
-
7.4 China Biologic Drugs Consumption (2017-2022)
-
7.5 Japan Biologic Drugs Consumption (2017-2022)
-
7.6 India Biologic Drugs Consumption (2017-2022)
-
7.7 South Korea Biologic Drugs Consumption (2017-2022)
8 Region and Country-wise Biologic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Biologic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Biologic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Biologic Drugs Consumption Forecast (2022-2028)
-
8.4 China Biologic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Biologic Drugs Consumption Forecast (2022-2028)
-
8.6 India Biologic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Biologic Drugs Consumption Forecast (2022-2028)
9 Global Biologic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Biologic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rituxan Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lantus Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Avastin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Herceptin Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Biologic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inflammation Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Auto-Immune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Blood Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Biologic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Biologic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Lantus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Biologic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Auto-Immune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Blood Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Biologic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Biologic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Biologic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Biologic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Biologic Drugs Market Competitive Analysis
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Details
-
14.1.2 Merck & Co Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Biologic Drugs Product and Service
-
14.2 Abbott Laboratories
-
14.2.1 Abbott Laboratories Company Details
-
14.2.2 Abbott Laboratories Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Laboratories Biologic Drugs Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Biologic Drugs Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Biologic Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Biologic Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Biologic Drugs Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Biologic Drugs Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Biologic Drugs Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Biologic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Biologic Drugs
-
Figure Biologic Drugs Picture
-
Table Global Biologic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biologic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biologic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Biologic Drugs Consumption by Country (2017-2022)
-
Figure United States Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Rituxan Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Lantus Consumption and Growth Rate (2017-2022)
-
Figure Global Avastin Consumption and Growth Rate (2017-2022)
-
Figure Global Herceptin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammation Consumption and Growth Rate (2017-2022)
-
Figure Global Auto-Immune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lantus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Auto-Immune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Biologic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Biologic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Biologic Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Biologic Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biologic Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Biologic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Biologic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Biologic Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Biologic Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Biologic Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Biologic Drugs Product and Service
-
